患者抗PLA2R1自身抗体在人PLA2R1转基因小鼠中诱发膜性肾病
该研究将PLA2R1相关膜性肾病患者纯化的IgG注射入足细胞表达人PLA2R1的Rag2缺陷小鼠,两周后小鼠出现蛋白尿、肾小球IgG和补体颗粒状沉积、足突融合及上皮下电子致密物,而对照未出现,证明抗PLA2R1自身抗体直接致病。
要点
- 抗PLA2R1 IgG被动转移可致转基因小鼠蛋白尿和膜性肾病病理改变
- 肾小球洗脱IgG仅识别PLA2R1,支持抗体特异性致病
- 结果支持以降低抗PLA2R1抗体水平为目标的治疗策略
核心结论
- 抗PLA2R1自身抗体对膜性肾病具有直接致病作用。
研究设计与样本
- 将PLA2R1相关膜性肾病患者纯化的IgG注射入足细胞表达人PLA2R1的Rag2缺陷小鼠。
- 对照为同一患者IgG去除后的血清及健康人纯化IgG。
主要发现
- 转移后两周,接受抗PLA2R1 IgG(主要为IgG4)的小鼠出现蛋白尿。
- 免疫荧光显示肾小球颗粒状人IgG及经典和替代途径补体成分沉积。
- 电镜显示足细胞足突融合和上皮下电子致密物,未见小鼠IgG沉积。
- 肾小球洗脱IgG仅识别PLA2R1。
临床怎么用
- 支持针对降低抗PLA2R1自身抗体水平的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The discovery of anti-phospholipase A2 receptor 1 (PLA2R1) autoantibodies in patients with membranous nephropathy (MN) has led to a paradigm change in diagnosis, monitoring, risk prediction, and therapy of this autoimmune disease. However, there is only limited data on the pathogenicity of these autoantibodies. METHODS: We purified the IgG from sera of patients with PLA2R1-associated MN and injected it into Rag2-deficient mice (mice lacking functional adaptive immunity) expressing human PLA2R1 in their podocytes. The IgG-depleted serum from the same patients and IgG purified from healthy individuals served as controls. RESULTS: Two weeks after transfer, mice receiving anti-PLA2R1 IgG (largely IgG4), but not IgG-depleted serum or control IgG, developed proteinuria and showed granular deposition of human IgG and complement components of both the classical and alternative pathways in glomeruli by immunofluorescence and podocyte foot process effacement and subepithelial electron dense deposits in electron microscopy. There was no mouse IgG deposited. The IgG eluted from glomeruli of anti-PLA2R1 IgG-injected mice exclusively recognized PLA2R1. CONCLUSIONS: Our findings provide evidence for a direct pathogenic role of anti-PLA2R1 autoantibodies, supporting the development of treatments aiming at the reduction of anti-PLA2R1 autoantibody levels.
引用
- Zahner G, Dehde S, Seifert L, et al. Patient anti-PLA2R1 autoantibodies cause membranous nephropathy in human PLA2R1 transgenic mice. Kidney Int. 2025. PMID: 41033458. doi:10.1016/j.kint.2025.08.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。